| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC1129 |
| Trial ID | JPRN-UMIN000031853 |
| Disease | T-Cell Lymphoblastic Leukemia/Lymphoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TBI-1301 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Investigator-initiated multi-institutional phase I clinical trial of NY-ESO-1-specific TCR gene-modified T cell therapy for adult T cell leukemia/lymphoma patients relapsed after allogeneic hematopoietic stem cell transplantation |
| Year | 2018 |
| Country | Japan |
| Company sponsor | Duke Clinical Research Institute |
| Other ID(s) | JapicCTI-183830 |
| Cohort 1 | |||||||
|
|||||||